Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

Exclusion Criteria

• •1. Patients with severe systemic diseases, such as heart or respiratory failure, liver or kidney failure, severe brain injury, prolonged bed rest, or incurable malignancies.
• •2. Pregnant women and breastfeeding mothers.
• •3. Patients who have taken Antrodia cinnamomea products within the last 6 months prior to the trial.
• •4. Patients with other factors that prevent them from continuing to participate in this study.